| Names | |
|---|---|
| Preferred IUPAC name | N-methyl-3-oxobutanamide |
| Other names | N-Methyl-3-oxobutanamide N-Methyl-3-oxobutyramide N-Methylacetoacetamid N-Methylacetoacetic acid amide |
| Pronunciation | /ɛn-ˈmɛθɪl-əˌsiːtoʊ-əˈsɛtəˌmaɪd/ |
| Identifiers | |
| CAS Number | 1118-74-5 |
| Beilstein Reference | Beilstein Reference: 606100 |
| ChEBI | CHEBI:84935 |
| ChEMBL | CHEMBL2081187 |
| ChemSpider | 23919 |
| DrugBank | DB08219 |
| ECHA InfoCard | 03f93c23-7e2e-49f4-beda-5aeff63179d3 |
| Gmelin Reference | 74150 |
| KEGG | C19136 |
| MeSH | D008681 |
| PubChem CID | 12541 |
| RTECS number | EL5950000 |
| UNII | HIV1UJQ57F |
| UN number | 2810 |
| CompTox Dashboard (EPA) | DJ5E07V32D |
| Properties | |
| Chemical formula | C5H9NO2 |
| Molar mass | 115.14 g/mol |
| Appearance | Colorless to yellow liquid |
| Odor | Odorless |
| Density | 1.046 g/mL at 25 °C |
| Solubility in water | soluble |
| log P | -0.44 |
| Vapor pressure | 0.02 mmHg (25°C) |
| Acidity (pKa) | 24.1 |
| Basicity (pKb) | pKb = 13.10 |
| Magnetic susceptibility (χ) | -6.78 × 10⁻⁷ |
| Refractive index (nD) | 1.453 |
| Viscosity | 1.8 cP (25 °C) |
| Dipole moment | 3.89 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 237.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -260.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -504.9 kJ/mol |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Precautionary statements: P261, P280, P305+P351+P338, P337+P313 |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 1, Instability: 0, Special: |
| Flash point | 96 °C |
| Autoignition temperature | 340 °C |
| Explosive limits | Explosive limits: 1.8–11% |
| Lethal dose or concentration | LD50 oral rat 1540 mg/kg |
| LD50 (median dose) | LD50 (median dose): 2000 mg/kg (Rat, oral) |
| NIOSH | Not listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 mg/m³ |
| IDLH (Immediate danger) | Unknown |
| Related compounds | |
| Related compounds | N-Methylacetamide Acetoacetamide N,N-Dimethylacetoacetamide |
| Aspect | Description |
|---|---|
| Product Name | N-Methylacetoacetamide |
| IUPAC Name | N-Methyl-3-oxobutanamide |
| Chemical Formula | C5H9NO2 |
| Synonyms & Trade Names |
N-Methylacetoacetamide N-Methyl-3-oxobutanamide 3-Oxobutanamide, N-methyl- Acetoacetamide, N-methyl- |
| CAS Number | 1694-31-1 |
| HS Code & Customs Classification |
Customs allocations for acetoacetamide derivatives generally fall under HS code 2924.19 for acyclic amides and derivatives, with the exact assignment determined by national harmonization and chemical structure disclosure on shipping documents. Regional variations in customs nomenclature can affect the tariff line used, so specification confirmation is required by the importing country’s authorities. For bulk and intermediate shipments, importers often provide customs with the IUPAC name, CAS number, and chemical usage statement. |
Production of N-Methylacetoacetamide draws on standard acetoacetic ester aminolysis pathways, using defined ratios of N-methylamine to acetoacetic ester under temperature-controlled conditions. Raw material consistency plays a significant role in impurity profile, particularly with respect to side products such as diketones and secondary amides. Choice of solvent system during synthesis affects separation efficiency; aqueous systems may require more elaborate purification to suppress hydrolytic byproduct formation.
Key control points for batch consistency include monitoring methylamine excess, reaction temperature profile, and endpoint determination by nitrogen content or HPLC assay. Typical purification employs either liquid-liquid extraction or controlled crystallization. Variations in final physical properties such as appearance, melting point, or residue on ignition are closely tied to route selection and downstream washing sequence. Products intended for pharmaceutical or specialty intermediate applications generally specify narrower impurity tolerances compared to technical grade, affecting both analytical method selection and final QC parameters.
Release specifications are always subject to the grade–pharmaceutical, reagent, or technical–with most critical differences found in residual solvent content, assay minimum, and presence or absence of minor structural isomers. Final batch acceptance is based on a combination of in-process control data and independent QC verification per defined internal SOPs and, where required, customer-specific quality agreements.
HS code attribution remains a customs compliance focal point. Importers must frequently align documentation to chemical structure and intended use, with variation possible depending on both the product’s substitution pattern and regional customs practices. Experience shows that reaching early agreement on customs classification with logistics and compliance teams prevents clearance delays.
Industrial users of N-Methylacetoacetamide are typically sensitive to trace contamination and solvent residues, especially for formulation or synthesis into active moieties. Storage and handling procedures reflect grade and use–product for custom synthesis commands more restrictive environmental control during both warehousing and transfer into process equipment.
Industrial batches of N-Methylacetoacetamide typically present as a colorless to pale yellow liquid, though minor color shifts may occur due to storage conditions or process variations. The liquid form prevails at ambient temperatures used in production and downstream handling. Volatility and low-to-moderate odor are noticed on open transfer, with the odor resembling those of related acetoacetamides. Solidification and melting points vary by impurity content, with freezing observed near refrigeration temperatures for higher-purity lots.
Boiling point assessments in the plant are often grade-dependent, as the presence of lower-boiling impurities or solvent residues may lower measured values. Density checks in production are run for each lot, revealing small variation dependent on temperature and impurity load.
The molecule resists slow hydrolysis under neutral to mildly basic conditions but may hydrolyze in the presence of excess acid, which motivates process and storage pH control. Contact with oxidants leads to decomposition, though practical workplace exposures to strong oxidizers are generally controlled. Prolonged thermal exposure near the upper end of the process temperature window can induce polymerization or decomposition, particularly in unpurified product lots.
N-Methylacetoacetamide displays full miscibility with polar solvents including water and alcohols typical for formulation. In industrial solution prep, gradual addition is preferred to manage exotherm and avoid local supersaturation. Quantitative dissolution occurs for freshly made product with minimal impact from common impurities, though aged batches or those containing high enol content may leave trace residues.
Exact specification tables are tailored for each product grade. Technical grade requirements focus on appearance, purity by chromatographic assay, and water content. Pharmaceutical or specialty grades introduce tighter controls on assay, residual solvents, and specific organic impurities in keeping with internal and regulatory-driven criteria.
Profile and permissible impurity levels are set per end-use. Most impurities stem from raw material excess, side reaction byproducts, or incomplete neutralization. Critical classes include residual starting amines, diketone condensation products, and minor oxidation derivatives. Maximum allowable concentrations for individual and total impurities reflect the grade and customer agreement rather than a universal standard.
Routine tests involve GC or HPLC assay, moisture check by Karl Fischer titration, and visual or instrumental color metrics. Purity and residual solvent analysis extend to GC-MS or NMR where required by customer application or region. The final release standard is subject to internal quality control criteria and customer requirements.
Main inputs include N-methylamine and acetoacetic ester, purchased to internal or contract specifications based on price, physical form, and contaminant profile. Feedstock selection impacts downstream impurity profile, so sourcing audits emphasize the traceability and reactivity of both major and minor components.
The standard synthesis routes follow either direct aminolysis or transacylation, where N-methylamine reacts with a diketone or ester under controlled temperature and mixing. Choice of solvent, temperature, and catalyst can vary between lines and is routinely reviewed based on safety, throughput, and environmental considerations.
Key control points involve feed ratio precision, temperature ramps, and endpoint monitoring to avoid overreaction and excessive byproduct formation. Purification typically involves multistage distillation and optionally, charcoal treatment to reduce color and absorb polar impurities. Final product is validated for batch homogeneity through refractometry and chromatographic fingerprinting.
Routine in-process sampling addresses purity, color, solvent removal, and byproduct content. Lots failing to meet contracted specifications are either reprocessed or downgraded. Batch consistency management is enforced by ongoing trending analysis of key impurity profiles and trace elements.
N-Methylacetoacetamide responds to alkylation, acylation, and condensation under standard laboratory and industrial conditions. The molecule functions as an intermediate for heterocycle synthesis, leveraging the methylene reactivity without excessive side reactions when pH, temperature, and solvent are correctly controlled.
Reactions are catalyzed by bases or acids as suitable for the targeted transformation. Temperature selection depends on substrate reactivity but remains below the boiling point to avoid loss or decomposition. Solvent choice is dictated by downstream isolation and volatility considerations.
N-Methylacetoacetamide serves as a feedstock for specialized pharmaceuticals, agrochemicals, and fine chemicals. Process modifications introduce various derivatives, relying on the retained functionality of the acetoacetamide group and selective protection or transformation.
Storage away from direct light and strong oxidants is standard practice to control degradation. Drum and bulk tank materials are matched to prevent extractable contamination. Moisture ingress avoidance extends product life.
Compatible container materials include stainless steel and specific polyethylene grades, avoiding phenolic liners. Not all grades tolerate long static storage in mild steel drums due to risk of discoloration or iron-catalyzed decomposition.
Shelf life is primarily determined by impurity buildup and changes in assay over time. Signs of degradation include color shift, off-spec odor, and the appearance of visible precipitates. Storage at lower temperature reduces both hydrolysis and oxidation rates but may increase viscosity or induce partial solidification in higher-purity batches.
Hazard and precautionary labeling aligns with the latest adopted GHS standards, which may differ by jurisdiction. Inhalation and skin contact risks are low to moderate in well-controlled environments. Acute toxicity data are monitored at the batch level where regulatory or customer-mandated for downstream applications.
Standard precautionary actions in production include ventilation, avoidance of skin and eye contact, and proper PPE use. Handling procedures reflect batch size, process configuration, and history of near-miss events.
Toxicological information is based on published and proprietary data sets, reviewed with each material revision or re-qualification cycle. No reliable chronic toxicity data are quoted without formal study. Acute exposure routes are managed by engineering and administrative controls.
Internal exposure guidelines define time-weighted average limits for workers based on available toxicological assessments and process emission survey data. Risk of adverse effects increases with vapor buildup or prolonged skin contact; routine monitoring verifies containment. Material-specific handling protocols are adjusted for task, packaging, and downstream integration requirements.
Current production output of N-Methylacetoacetamide depends on the configuration of each synthesis line and plant utilization rates. For industrial routes using methylamine and acetoacetic ester precursors, line capacity typically varies by reactor scale, processing time, and campaign planning. Available supply responds directly to scheduling constraints and batch campaign sizes, with constraints intensifying during plant maintenance, raw material supply disruptions, or export policy changes in key producing regions.
For technical and electronic grades, output is frequently balanced by existing long-term supply agreements; spot market tonnage availability tightens during strong downstream demand cycles in pharmaceutical and agrochemical sectors. Surplus capacity has narrowed as specialty chemical producers optimize batches to match customer forecast accuracy and reduce off-grade and inventory risks.
Lead time oscillates depending on production queue, batch turnaround requirements, and demand from contracted customers versus spot requests. The minimum order quantity (MOQ) is highly grade-dependent: technical and laboratory grades often start from drum or pail size, while electronic and pharmaceutical grades align to bulk or IBC minimums for validated production lots. Rapid fulfillment favors planned, forecasted contracts; unplanned orders are scheduled around batch campaign gaps where possible.
Packaging configuration affects both product protection and shipping compliance. For sensitive or high-purity grades, lined drums, anti-static IBCs, and UN-certified containers are common. Technical grades for resin or intermediate use may be supplied in bulk, HDPE drums, or steel containers. Some applications require nitrogen blanketing and tamper-evident seals. Packaging selection remains closely tied to product grade, shipment route, and end-user handling constraints.
Shipping terms favor regional optimization: domestic shipments are often FOT plant or DDP site depending on customer infrastructure, while international logistics vary by customer preference (FOB, CIF, DAP). Payment terms align to grade and customer profile, often net 30 for established clients. Letters of credit and advanced payment terms are required for export shipments into high-risk or new markets, especially for sensitive or regulated grades.
Raw material costs trace directly to methylamine and acetoacetic ester price trends. Sourcing logic prioritizes stable, compliant suppliers with consistent lot purities to minimize downstream impurity loads. Volatility in crude oil, acetone, or ammonia markets can cascade into precursor chemical price shifts.
Energy intensity of synthesis and purification operations, as well as local utility pricing, feed into total cost structure. Storage, transport regulations, byproduct disposal, and quality control testing contribute additional layers to final delivered cost.
Raw material volatility often arises from seasonal supply tightness, plant shutdowns, regional political risk, or force majeure events at key upstream manufacturers. Regulatory interventions (e.g., hazardous substance reclassification) can constrain permissible routes or require new compliance investments, contributing to supply uncertainty and cost increases.
Price shifts also track changes in downstream demand. Periods of strong growth in pharmaceutical or electronic application segments can produce rapid spike buying, often outpacing producer flexibility and pushing available spot prices well above contract benchmarks.
Product pricing diverges sharply based on grade, purity, packaging, and third-party certification requirements. Electronic- and pharma-grade lots must clear strict impurity ceilings and often include batch traceability, detailed CofA documentation, and pre-shipment analytical support, inflating per-unit cost versus technical or industrial grades.
Packaging requirements (e.g., sterile filling, inert atmosphere, double containment for export) further increase price for specialty or validated lots. Certification for GMP, Halal, Kosher, or niche compliance adds significant documentation and release overhead. End-use determines both required grade and corresponding price tier, with bulk/lower-purity lots aligned to competitive spot market rates.
Supply-demand balance reflects regional production concentrations: East Asia, North America, and major European chemical clusters account for significant capacity. Upstream supply chain security, refinery output, and precursor access can shift market share year over year. Industrial users in electronics, pharma, and agchem drive core demand, with periodic surges linked to regulatory approvals and new product launches.
| Region | Market Dynamics |
|---|---|
| US | Driven by electronic, biotech, and custom synthesis industries; tight control on purity, traceability, and secondary certification. |
| EU | Stringent REACH compliance, periodic disruptions from energy pricing and site audits; increased demand from regulated pharma and green chemistry sectors. |
| JP | High consistency standards, demand for microelectronic-grade material, limited domestic production supplemented by controlled imports. |
| IN | Growing downstream processing; market split between local technical grades and rising imports for export pharmaceuticals; regulatory changes impact import certification costs. |
| CN | Large-scale production, influence of local government policies on supply/export, oversupply or shortages possible depending on plant outages and national chemical management policy shifts. |
Forward projections rest on upstream volatility, tightening environmental scrutiny, and downstream demand outlook. Anticipated constraints in high-purity supply, along with evolving export approvals, could drive structure toward firming contract prices and increased spot premiums for specialty lots. Fluctuations in global energy markets and regional regulatory changes are expected to amplify short-term price swings.
Market tracking relies on monthly purchase order data, producer feedstock cost indices, and publicly reported interregional trade flows. Additional validation comes from buyer tenders, certification requirement databases, and regional producer association statistics. Trend analysis integrates historical price benchmarking and direct partner feedback on emerging regulatory and supply challenges.
Export logistics disruptions have complicated timely delivery—particularly for high-value, certified grades requiring temperature or security controls. Recent shifts in precursor production, driven by both environmental regulation and uneven recovery from pandemic impacts, have created supply inconsistencies at certain times of year.
Regulatory activity continues to influence both route selection and documentation. Implementations of stricter handling and export licensing for certain amides and related precursors have raised compliance costs, especially for cross-border shipments and specialty pharmaceutical uses. Producers have responded with additional lot traceability and expedited in-process audit protocols for regulated destinations.
Manufacturers have expanded dual-sourcing for key precursors and upgraded in-line purity monitoring to keep pace with end-user specification tightening. Batch campaign scheduling now includes flexible windows for demand spikes and transport delays. Continuous improvement in purification, packaging customization, and certification support drives both reliability and compliance resilience, maintaining customer supply under challenging market and regulatory conditions.
N-Methylacetoacetamide serves in several segments, each requiring distinct purity standards and performance characteristics. Its main demand arises in pharmaceutical synthesis, agrochemical intermediates, and specialty coatings. Process chemists and R&D teams value its reactivity and solvent properties. The resin and pigment industries sometimes specify it as a modifying agent, and certain textile processing routes call for selective grades.
| Application Sector | Typical Grade Range | Parameter Sensitivity |
|---|---|---|
| Pharmaceutical Precursors | High Purity / API-Directed | Purity profile, trace metal content, moisture |
| Agrochemical Formulation | Technical Grade | Impurities, residual solvents, consistency |
| Specialty Coatings/Polymers | Standard/Technical Grade | Water content, color, residue control |
| Textile Processing | Standard/Industrial Grade | Bulk impurities, odor, surface-active impurities |
Identify the exact process or final use. High-purity synthesis demands a different supply chain and QC protocol than a use in bulk intermediates for agriculture or resins. Experienced procurement teams seek feedback from their downstream technical teams before locking grade requirements.
Check mandatory compliance codes, whether pharmaceutical, REACH, or local chemical control regulations. Not all grades meet every requirement; declaration data and origin traceability need to be confirmed for each shipment.
Assess if the downstream tolerance for byproducts, trace chemicals, or moisture aligns with standard offering or requires custom manufacture. Default grade classifications vary: a batch for pharma might demand double-checking specific impurity classes, while technical segments tolerate broader profiles, provided critical limits are controlled. Consult technical support for impurity patterns or historical batch trends if process risk is high.
Production scale impacts grade economics. High-purity and low-metal variants draw significantly more in process time, testing, and yield losses. Aligning required batch volumes with realistic price and lead times prevents last-minute disruptions, especially for projects under scale-up or regulatory review.
Conduct laboratory- or pilot-scale validation on actual process lines, especially when switching suppliers, shifting application field, or introducing a new product grade. In-house QC should benchmark sample performance against main production lots. Only after successful validation should procurement proceed with larger volume commitments.
Each grade stems from a designated process route: raw material selection, reaction control points, and purification steps all drive impurity profiles and batch consistency. Typical impurity sources trace back to residual starting materials or undesired side reactions. Technical staff routinely monitor reaction endpoints and intermediate sample points for off-spec values. Where volume permits, batches are blended for target parameter consistency before release. Internal release criteria reflect customer application data, historical performance trends, and ongoing feedback loop with downstream users. Continuous batch documentation and traceability are maintained for each manufactured lot, supporting both process review and third-party audit needs.
Production of N-Methylacetoacetamide follows structured process control systems supported by formal quality management certifications that address consistency and traceability from raw material intake through final packaging. These certifications, commonly maintained in facilities supplying industrial, pharmaceutical, or specialty sectors, reflect internal control, regular procedure audits, and adherence to recordkeeping practices that withstand customer and regulatory review. Auditable documentation supports batch genealogy, process deviation management, and traceable corrective actions during upstream or downstream events.
Certification requirements for N-Methylacetoacetamide differ according to end-use segment and geographical market. For downstream applications demanding low impurity and specific functional profiles, the plant can provide process-tailored release criteria, including certificates of analysis, batch test summaries, and third-party validation when specified by mutual agreement. Some applications require global or regional standards; these are coordinated as part of supply chain agreements and may involve plant or third-party verification protocols, depending on grade and customer expectations.
Customers typically request full COAs with each shipment, containing both in-process and post-packaging analytical parameters as determined by internal QC, with methods referenced against accepted industry or customer standards as applicable for the supplied grade. Custom data sets for impurity profiles or physical properties can be provided for application-specific procurement, upon advance technical alignment. Retained samples, production batch records, and technical summaries remain archived according to internal policy, facilitating subsequent regulatory or customer inspection activities.
Facility design and core operator experience support a reliable output for N-Methylacetoacetamide, aiming to cushion routine industrial cycles and unplanned disruptions. Capacity commitments are aligned with raw material security strategies and production schedule optimization, with the aim of reducing lead times for volume orders. Flexible arrangements accommodate contracted delivery, scheduled call-offs, and periodic ordering suited to fluctuating demand, subject to forewarning and capacity alignment.
Manufacturing lines run with fully controlled key process steps, from raw material prequalification through batch monitoring and intermediate isolation. Final product quality relies on proactive impurity mapping, equipment maintenance, and operator certification. Capacity allocation is periodically reviewed based on customer order history, market forecasts, and input material flows. Customers with ongoing volume requirements benefit from shared production planning, which helps secure availability through market volatility.
Sample requests for N-Methylacetoacetamide follow standardized internal procedures: specification alignment or stated end-use, review of application intent, and authorization of the appropriate product grade or lot. Technical support accompanies the sampling process to help customers validate suitability for their process or formulation goals. Typical lead time and volume for sampling depend on the grade, regulatory requirements, and transport conditions for specific regions. All sample shipments include traceable batch history.
Cooperation frameworks range from trial and pilot batch support for new developments, through fixed-volume contracts, to rolling-call off agreements with dynamic order adjustments. Minimum order quantity, response time, and shipping intervals can be adapted for different industry segments, acknowledging that pharmaceutical, agricultural, or specialty chemical players face unique procurement and regulatory landscapes. Long-term agreements often involve periodic technical reviews, joint quality audits, and escalation channels for deviation management. These practices help align operational realities with customer priorities on continuity, escalation management, and process disclosure.
Manufacturing teams currently investigate synthesis routes for N-Methylacetoacetamide that aim to optimize raw material conversion while limiting by-product formation at each step. Direct methylation remains an area of attention in process design, with ongoing efforts to enhance the selectivity toward the target amide compared to side-reactions such as over-methylation. Downstream purification improvements, including solvent selection and phase-separation techniques, continue to be prioritized to maintain batch consistency and recover intermediates.
Process chemists keep monitoring the generation of N-methylacetamide or acetoacetic acid residues, recognizing these as both efficiency and quality control points. Tailoring the process approach to the customer’s required purity profile supports performance in sensitive downstream applications, such as pharmaceutical and agrochemical synthesis.
R&D observes growing demand for products meeting higher purity and lower residual solvent profiles, particularly in active pharmaceutical ingredient (API) intermediates and specialty resin formulations. Performance in crop protection formulation also prompts grade-specific changes, as end users ask for amide grades compatible with regulatory limits for agricultural markets. New research explores use in advanced catalysis and controlled-release materials, driving specialty producers to explore co-monomer compatibility and analytical traceability within those new application classes.
The primary technical hurdle arises from balancing raw material choice and minimizing thermal degradation during processing. Continuous process improvement efforts focus on reducing the formation of colored or high-boiling impurities. Any trace-level contaminants, for example low molecular weight amines or diketones, can challenge downstream formulation or shelf life, so ongoing breakthroughs include in-line purity sensing and closed-loop temperature control. Breakthroughs in solvent recovery, as piloted in-house, also contribute to reducing both operational costs and environmental load.
Industry analysts and production managers track increasing demand from regulated sectors. Short-term projections indicate volume growth in pharmaceuticals, owing to new drug synthesis protocols, and in polymeric materials for electronics binders. Long-term demand remains highly dependent on how regional regulatory changes might define acceptable impurity thresholds, which in turn drives grade differentiation. Manufacturers expect a shift toward contract-customized amides supporting proprietary applications in Asia-Pacific and Europe, emphasizing need-based batch specifications.
Process technology in this segment moves toward inline analytical control and flexible batching. Reaction pathway selection considers raw material supply chain reliability and downstream process safety. Plants invest in real-time GC or HPLC for documenting quality release for each lot, with tailored purification and filtration steps for each customer’s grade. Strategy includes modular upgrades to adapt quickly to new application sectors emerging from advanced polymers and precision chemicals.
Green chemistry adoption builds on solvent recovery and renewable-based starting materials, reducing overall carbon footprint. Process changes focus on waste minimization by closed recycling of reaction media and side stream valorization. Teams investigate biocatalytic routes and low-energy reaction conditions to produce N-Methylacetoacetamide suitable for eco-labeled product grades. Internal audits and supply chain surveys evaluate the reduction of volatile organic emissions, with metrics tracked to customer sustainability scorecards.
Chemists and process engineers provide direct consultation for application questions, addressing raw material compatibility, downstream reactivity, and impurity risk management. Support covers guidance on best storage practices at user sites, tailored to the supplied grade – for instance, by advising inert atmosphere storage for moisture-sensitive applications or temperature tracking for shelf stability concerns.
Technical teams remain available for on-site and remote troubleshooting, particularly for formulation optimization and unexpected quality deviations. Customers using amide blends for API, coatings, or resin synthesis may require joint studies or pilot-scale testing to solve batch-to-batch variability. Data on previous customer feedback supports formulation recommendations, with detailed root cause analyses documented for each major case.
Each shipment release ties to in-house batch testing and retained sample management for traceability. Manufacturers honor commitments to product complaint investigations with thorough re-testing and full lot record access. Feedback from application end use is routed into batch release criteria revisions and formulation protocols for future production runs. Quality assurance teams maintain transparent records and offer to adapt packaging or logistics to ensure product performance up to the point of consumption.
As a chemical manufacturer, our N-Methylacetoacetamide output is the result of strict process control from raw material selection to final packaging. Each batch comes from reactors within our facility using proprietary process conditions tuned over years of continuous operation. Advanced monitoring tracks reaction kinetics, impurity profiles, and end-point composition, so only product meeting our internal standards moves forward. Our in-house analytical capacity covers both routine and trace impurity testing for every lot.
N-Methylacetoacetamide finds significant demand in the pharmaceutical, agrochemical, and fine chemical sectors. Process chemists rely on its amide group for acylation, condensation, and selective methylation, particularly where reproducibility matters in multi-step synthesis. Agrochemical formulators use this compound as a building block for intermediate synthesis and crop protection algorithms. Engineered resin producers include it as a controlled solvent or intermediate where thermal and chemical resistance matters.
Industrial buyers set high demands for analytical consistency and low batch-to-batch deviation. We meet these requirements using closed system production, rigid cleaning protocols, and lot traceability down to single-kilogram packaging. Routine HPLC and NMR screening back every outgoing batch. Periodic stability studies demonstrate that our packaging and storage methods preserve material integrity throughout transport and storage cycles.
Manufacturing at scale lets us supply N-Methylacetoacetamide in drum, IBC, or bulk liquid tanker formats. Orders from specialty formulators to large-volume multinational plants ship on fixed schedules from our logistics hub. Custom packaging, such as nitrogen-blanketed containers, supports sensitive downstream applications and extended shelf life. Our inventory management system delivers transparency on lot availability and real-time delivery updates for procurement teams.
Process development and technical scale-up often raise concerns about reactivity, handling, and solvent compatibility. Our team offers direct access to application chemists and process engineers responsible for our production lines. Their experience with application troubleshooting, impurity isolation, and system cleaning procedures supports routine operations and new project launches.
We guarantee lead-time control, planned batch reservation, and secure contract manufacturing volumes. Manufacturers benefit from direct dialogue on technical adjustments or regulatory documentation. Distribution partners gain clear pipeline updates for just-in-time inventory planning. Procurement officers can tap historical delivery data to analyze risks and optimize purchasing schedules, avoiding speculative market variables found outside the direct producer level. Our singular focus on N-Methylacetoacetamide manufacturing underpins both price stability and long-term supply reliability for commercial partners.
At our manufacturing facility, N-Methylacetoacetamide comes off the production line under controlled conditions aimed at delivering a consistent chemical profile batch after batch. Customers ask about purity and structure because those qualities affect downstream applications, whether as an intermediate in synthesis, a specialty solvent, or a reagent for research and industry.
We supply N-Methylacetoacetamide with purity typically exceeding 98%. Our technical team relies on established methods such as gas chromatography (GC) and high-performance liquid chromatography (HPLC) during final QC. These techniques reveal impurities and byproducts from synthesis. By designing the process to minimize residual solvent, starting material, and side reactions, we keep impurity levels under tight control.
Color and clarity provide a visible indicator of quality, but instrument-based assays remain the standard in the factory. Loss on drying, water content by Karl Fischer, and elemental analysis round out the routine batch release checks. For specialized applications, we can run extended impurity profiling or offer higher grades on request. Our plant puts a priority on analytical transparency—the data supporting each lot can be supplied for technical review.
Producing a chemical like N-Methylacetoacetamide means backing up product claims with hard evidence. Our QC laboratory carries out nuclear magnetic resonance (NMR) spectroscopy to confirm structure. Both proton (1H) and carbon (13C) NMR give resonance signals that identify methylation at the nitrogen and substitution patterns on the acetoacetamide backbone. These spectra are recorded and archived for traceability.
Infrared (IR) spectroscopy further verifies the presence of functional groups, picking up characteristic amide and ketone stretches in the molecule. Mass spectrometry (MS) gives insight into molecular weight and fragmentation, confirming the molecular formula. In some cases, we supplement these results with melting point determination and comparison to literature data, supporting full identification for regulatory and customer scrutiny.
Our analytical records go beyond lot traceability—they form evidence for audits, customer qualification, and registration filing. Our team maintains a direct link between production logs and the full characterization dossier for each lot released.
Producing high-purity N-Methylacetoacetamide at scale introduces challenges, especially in controlling trace byproducts and ensuring full batch homogeneity. Process optimization is ongoing: from raw material quality to reaction conditions and purification steps, each stage is monitored and refined based on feedback from our own analytical results and customer performance data.
By collecting real production and analytical data in house, we avoid guesswork. Our customers require clear specifications and reliable supply. Industrial users with downstream regulatory filings, such as in the pharmaceutical or agrochemical sectors, count on documentation for every consignment. We maintain these technical packages and update our processes as new standards arise.
As an established direct manufacturer, we communicate openly with industrial and research partners. Our technical documentation covers both purity figures and full analytical characterization. We support method transfer, provide samples for qualification, and maintain open scientific dialog regarding critical quality attributes. If customers require additional data for specific compliance, our team responds quickly from the lab bench, not a call center or third-party trader.
At our chemical plant, we understand that secure supply chains and consistent quality drive the value our customers expect. N-Methylacetoacetamide features in several applications, from fine chemicals to pharmaceuticals, so our order process is designed for both reliability and flexibility.
We set our minimum order quantity (MOQ) on a foundation of manufacturing efficiency, safe logistics, and material shelf-life. MOQ for N-Methylacetoacetamide is determined by the technical requirements built into both our synthesis process and our standard package size. This usually equates to a full drum, commonly 200 kilograms net. This MOQ ensures product consistency over each batch, especially important for clients who operate under validated quality control systems. By moving at this scale, we maintain high purity and guarantee homogeneous batches, which can otherwise be difficult or costly in micro-scale runs.
Requests below the minimum often break the cost curve — changes in raw material handling, packaging risks, and quality checks drive up per-kilogram cost sharply on sub-batch sizes. Over the years in production, we’ve seen that meeting the MOQ delivers efficiency on both ends: our shop floor keeps product flowing, and customers avoid unnecessary secondary sampling or variable yields.
Realistic lead times are about working with the calendar of chemical synthesis, not just the shipping schedule. For standard orders of N-Methylacetoacetamide, our typical lead time falls between two and four weeks from receipt of purchase order. This timeframe reflects our batch synthesis schedule, third-party testing (where specified), and the coordination involved in safe packing for transport.
We allocate production campaigns for this compound in waves, planning in line with both raw material delivery and downstream customer demand forecasts. Re-stocking happens continuously, but if a custom grade or extra testing is required, that sometimes adds five to ten days to the lead time. Any urgent or time-critical order weighs on the technical team — we review on a case-by-case basis to avoid disruption to ongoing campaigns. Within the last two years, most of our repeat clients have come to rely on the predictability of our published timelines since spot purchasing in this sector quickly leads to stockouts or quality compromises.
We recognize the stakes: manufacturers need predictability not just on cost, but also on when product will reach their tank or blender. Consistent minimum order quantities and achievable lead times make it possible to plan inventory around production peaks, qualification runs, and seasonal logistics. If supply interruptions surface due to force majeure or upstream changes, we inform partners immediately and work off buffer stocks if available. Over decades in the plant, this trust has kept even the highest scrutiny audit trails clear and reduced idle time at customer sites.
For technical details about our standard packaging, storage guidelines, or to align future orders for N-Methylacetoacetamide into your material scheduling system, our technical sales and logistics staff are prepared to consult directly on actual requirements. Supporting long-term relationships is how we keep our lines running and our customers ahead in their own markets.
N-Methylacetoacetamide, used across a wide range of industrial and research applications, falls under the scrutiny of global chemical shipping guidelines. Handling and documentation receive a lot of attention from our shipping partners, and for good reason. In global trade, clarity and compliance reduce risk—not only for safety but also for punctual delivery and regulatory confidence on both sides of the order.
From our experience on the production line to the loading docks, N-Methylacetoacetamide typically ships as a non-hazardous liquid. Still, regulations shift from region to region. Our logistics teams review up-to-date rules from organizations such as the International Air Transport Association (IATA) and the International Maritime Dangerous Goods Code (IMDG), as well as local requirements in each destination country. The regulations set out by the UN’s Globally Harmonized System (GHS) drive labeling and classification rules. For ground transport in North America, the Department of Transportation (DOT) offers a separate framework. Most authorities look at flash point, toxicity, and corrosivity before making a call on hazardous status. To date, based on regulatory review and product data, N-Methylacetoacetamide does not trigger hazardous substance thresholds, but that does not mean skipping due diligence. Each shipment clears with a material safety data sheet (SDS) that reflects the latest data from our laboratory and documents our most recent toxicological and physical property reviews.
Our shipping documentation includes a commercial invoice, packing list, and a compliant SDS. We provide a certificate of analysis (COA) for every batch, which authenticates purity, moisture levels, and key characteristics established in our quality control suite. For many destinations in Asia, a chemical registration or import license number appears on the shipping paperwork, so our documentation process matches local customs demands to avoid delays. Customs authorities often check harmonized codes to classify goods properly; our export and compliance office keeps these numbers current based on our manufacturing process and final chemical identity.
Proper packaging protects both cargo and handlers. Our standard drum and IBC options come rated to withstand the rigors of international transit. Each container uses a tamper-evident seal, barcode traceability, and bilingual labeling following GHS pictograms and mandatory statements. We supply the SDS in English plus the language of the destination country upon request. For customers under REACH regulations in the EU, we offer a full registration dossier and ensure labeling matches all obligations under current European law.
Some end-users face delays due to incomplete documentation, misidentified product codes, or insufficient registration at the destination. To minimize risk, our compliance and export staff collaborate directly with customers before dispatch, confirming specifications and clarifying all paperwork. For shipments bound for countries with shifting standards, we keep updated with regulatory bulletins and involve our legal and safety specialists in pre-shipment protocol. Whenever we see opportunities to improve traceability—whether through electronic export records or enhanced label scanning—we invest in those solutions to improve visibility for everyone in the supply chain.
Shipping chemicals internationally requires technical accuracy and discipline. Our direct manufacturing and export controls keep shipments moving, reduce avoidable hold-ups, and protect our clients’ bottom line. Reliable documentation, mandatory compliance, and careful listening to customer needs keep us moving forward, batch by batch, container by container.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
